Publications by authors named "Simon Yunger"

Claim this Profile
E
Economic evaluation of rituximab in addition to standard of care chemotherapy for adult patients with acute lymphoblastic leukemia.
Julian Nam, Robert Milenkovski, Simon Yunger, Marc Geirnaert, Kristjan Paulson

J Med Econ· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer Compared to Capecitabine Plus Lapatinib from the Perspective of the Canadian Health-Care System.
Charles Piwko, Catherine Prady, Simon Yunger, Erika Pollex, Aurelie Moser

Clin Drug Investig· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC).
Donna Lawrence, Michael Maschio, Kevin J Leahy, Simon Yunger, Jacob C Easaw

J Med Econ· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis